Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of “Second Hit” in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma

BACKGROUND AND OBJECTIVE: Pancreatic ductal adenocarcinoma (PDAC) is characterized by the occurrence of pathogenic variants in BRCA1/2 in 5–6% of patients. Biallelic loss of BRCA1/2 enriches for response to platinum agents and poly (ADP-ribose) polymerase 1 inhibitors. There is a dearth of evidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng-Lin, Binbin, Rainone, Michael, Varghese, Anna M., Yu, Kenneth H., Park, Wungki, Berger, Michael, Mehine, Miika, Chou, Joanne, Capanu, Marinela, Mandelker, Diana, Stadler, Zsofia K., Birsoy, Ozge, Jairam, Sowmya, Yang, Ciyu, Li, Yirong, Wong, Donna, Benhamida, Jamal K, Ladanyi, Marc, Zhang, Liying, O’Reilly, Eileen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626413/
https://www.ncbi.nlm.nih.gov/pubmed/36178671
http://dx.doi.org/10.1007/s40291-022-00614-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626413/
https://www.ncbi.nlm.nih.gov/pubmed/36178671
http://dx.doi.org/10.1007/s40291-022-00614-1

Ejemplares similares